155 related articles for article (PubMed ID: 34940918)
1. [Grading of tumor regression of gastrointestinal carcinomas after neoadjuvant therapy].
Liu D; Langer R
Pathologe; 2022 Feb; 43(1):51-56. PubMed ID: 34940918
[TBL] [Abstract][Full Text] [Related]
2. Tumor regression grading of gastrointestinal cancers after neoadjuvant therapy.
Langer R; Becker K
Virchows Arch; 2018 Feb; 472(2):175-186. PubMed ID: 28918544
[TBL] [Abstract][Full Text] [Related]
3. Tumor regression grading of gastrointestinal carcinomas after neoadjuvant treatment.
Thies S; Langer R
Front Oncol; 2013 Oct; 3():262. PubMed ID: 24109590
[TBL] [Abstract][Full Text] [Related]
4. Interobserver agreement of a gastric adenocarcinoma tumor regression grading system that incorporates assessment of lymph nodes.
Tsekrekos A; Vieth M; Ndegwa N; Bateman A; Flejou JF; Grabsch HI; Mastracci L; Meijer SL; Saragoni L; Sheahan K; Shetye J; Yantiss R; Lundell L; Detlefsen S
Hum Pathol; 2021 Oct; 116():94-101. PubMed ID: 34284051
[TBL] [Abstract][Full Text] [Related]
5. Tumor regression grading after neoadjuvant treatment of esophageal and gastroesophageal junction adenocarcinoma: results of an international Delphi consensus survey.
Saliba G; Detlefsen S; Carneiro F; Conner J; Dorer R; Fléjou JF; Hahn H; Kamaradova K; Mastracci L; Meijer SL; Sabo E; Sheahan K; Riddell R; Wang N; Yantiss RK; Lundell L; Low D; Vieth M; Klevebro F
Hum Pathol; 2021 Feb; 108():60-67. PubMed ID: 33221343
[TBL] [Abstract][Full Text] [Related]
6. [Study on the relationship between tumor regression grade and lymph node regression grade].
Zhao Q; Fu C; Yu E; Zhang W; Meng R; Wang H; Hao L; Wang H
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1050-1054. PubMed ID: 28900999
[TBL] [Abstract][Full Text] [Related]
7. Pathological Tumor Regression Grade Classifications in Gastrointestinal Cancers: Role on Patients' Prognosis.
Fanelli GN; Loupakis F; Smyth E; Scarpa M; Lonardi S; Pucciarelli S; Munari G; Rugge M; Valeri N; Fassan M
Int J Surg Pathol; 2019 Dec; 27(8):816-835. PubMed ID: 31416371
[TBL] [Abstract][Full Text] [Related]
8. College of American Pathologists Tumor Regression Grading System for Long-Term Outcome in Patients with Locally Advanced Rectal Cancer.
Chen HY; Feng LL; Li M; Ju HQ; Ding Y; Lan M; Song SM; Han WD; Yu L; Wei MB; Pang XL; He F; Liu S; Zheng J; Ma Y; Lin CY; Lan P; Huang MJ; Zou YF; Yang ZL; Wang T; Lang JY; Orangio GR; Poylin V; Ajani JA; Wang WH; Wan XB
Oncologist; 2021 May; 26(5):e780-e793. PubMed ID: 33543577
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of tumour regression grade following neoadjuvant chemoradiation therapy for rectal cancer.
Abdul-Jalil KI; Sheehan KM; Kehoe J; Cummins R; O'Grady A; McNamara DA; Deasy J; Breathnach O; Grogan L; O'Neill BD; Faul C; Parker I; Kay EW; Hennessy BT; Gillen P
Colorectal Dis; 2014 Jan; 16(1):O16-25. PubMed ID: 24119076
[TBL] [Abstract][Full Text] [Related]
10. What Is the Ideal Tumor Regression Grading System in Rectal Cancer Patients after Preoperative Chemoradiotherapy?
Kim SH; Chang HJ; Kim DY; Park JW; Baek JY; Kim SY; Park SC; Oh JH; Yu A; Nam BH
Cancer Res Treat; 2016 Jul; 48(3):998-1009. PubMed ID: 26511803
[TBL] [Abstract][Full Text] [Related]
11. Tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: updated results of the CAO/ARO/AIO-94 trial.
Fokas E; Liersch T; Fietkau R; Hohenberger W; Beissbarth T; Hess C; Becker H; Ghadimi M; Mrak K; Merkel S; Raab HR; Sauer R; Wittekind C; Rödel C
J Clin Oncol; 2014 May; 32(15):1554-62. PubMed ID: 24752056
[TBL] [Abstract][Full Text] [Related]
12. Connection and distinction of tumor regression grading systems of gastrointestinal cancer.
Tong Y; Liu D; Zhang J
Pathol Res Pract; 2020 Sep; 216(9):153073. PubMed ID: 32825946
[TBL] [Abstract][Full Text] [Related]
13. Can tumor regression grade influence survival outcome in ypT3 rectal cancer?
Shen L; Wang L; Li G; Zhang H; Liang L; Fan M; Wu Y; Deng W; Sheng W; Zhu J; Zhang Z
Clin Transl Oncol; 2016 Jul; 18(7):693-9. PubMed ID: 26527031
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of visual residual tumour cells (VRTC) for patients with esophageal squamous cell carcinomas after neoadjuvant therapy followed by surgery.
Wang X; Wang H; Wang H; Huang J; Wang X; Jiang Z; Tan L; Jiang D; Hou Y
BMC Cancer; 2021 Feb; 21(1):111. PubMed ID: 33535987
[TBL] [Abstract][Full Text] [Related]
15. Histomorphological tumor regression grading of esophageal carcinoma after neoadjuvant radiochemotherapy: which score to use?
Hermann RM; Horstmann O; Haller F; Perske C; Christiansen H; Hille A; Schmidberger H; Füzesi L
Dis Esophagus; 2006; 19(5):329-34. PubMed ID: 16984527
[TBL] [Abstract][Full Text] [Related]
16. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
[No Abstract] [Full Text] [Related]
17. Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in China.
Zhu Y; Sun Y; Hu S; Jiang Y; Yue J; Xue X; Yang L; Xue L
BMC Gastroenterol; 2017 Mar; 17(1):41. PubMed ID: 28292272
[TBL] [Abstract][Full Text] [Related]
18. Varying practices in tumor regression grading of gastrointestinal carcinomas after neoadjuvant therapy: results of an international survey.
Westerhoff M; Osecky M; Langer R
Mod Pathol; 2020 Apr; 33(4):676-689. PubMed ID: 31673084
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of pathological tumor regression grade in locally advanced gastric cancer: New perspectives from a single-center experience.
Lombardi PM; Mazzola M; Achilli P; Aquilano MC; De Martini P; Curaba A; Gualtierotti M; Bertoglio CL; Magistro C; Ferrari G
J Surg Oncol; 2021 Mar; 123(4):923-931. PubMed ID: 33497471
[TBL] [Abstract][Full Text] [Related]
20. A new magnetic resonance imaging tumour response grading scheme for locally advanced rectal cancer.
Pang X; Xie P; Yu L; Chen H; Zheng J; Meng X; Wan X
Br J Cancer; 2022 Jul; 127(2):268-277. PubMed ID: 35388140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
